Let's take a closer look at the scientific principles, technological progress, and translational hurdles defining the present state of microneedle research.
- Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
- Biomaterials In Ophthalmology Are Reshaping Ocular Drug Delivery
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Minimizing API Supply Chain Risks
Partnering with an API CMO can help you navigate challenges you may encounter, ensuring you are using the best quality practices and minimizing delays in getting those medicines to market.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C
This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
A New Framework For Identifying Nitrosamine Risks And Derisking Products
Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Building Sustainability Into Medical Devices
Medical device waste is a growing problem in the pharmaceutical industry. Learn how to navigate the balance between sustainability and factors like performance, safety, and regulatory compliance.
-
Addressing Glass Particulates In Injectable Drug Formulations
Learn how a new vial design that is capable of reducing the propensity for glass particulate generation on filling lines is enabling a significant, positive impact on product quality and safety.
-
Contract Design And Development Vs. In-House: Finding The Best Fit
Outsourcing medical device R&D to Contract Development Organizations (CDOs) aids innovation, scales resources, and overcomes constraints. Strategic evaluation ensures successful partnerships.
-
The Role Of Psychological Principles In Med Device Training Design
Explore how psychological principles can shape the design of medical device training and the significance of these principles in developing an effective training protocol for new medical device users.
-
FAQs On The Revised EU GMP Annex 1: Volume 1
The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing
In this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.

